Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Rev Neurol ; 26(152): 537-40, 1998 Apr.
Artigo em Espanhol | MEDLINE | ID: mdl-9795999

RESUMO

INTRODUCTION: Studies of neural transplants in experimental models of Parkinson's disease have concentrated their attention on ectopic transplants of foetal mesencephalic cells to denervated striatum. However, the external globus pallidus has recently been shown to play an important part in the physiopathology of this disease. OBJECTIVE: Bearing in mind the importance of loss of extra-striatal dopamine in the genesis of the clinical signs found in parkinsonism, the objective of this study was to evaluate the effect of foetal mesencephalic transplantation to the globus pallidus of hemiparkinsonian rats. MATERIAL AND METHODS: Following conventional transplantation methodolgy, suspensions of cells from the ventral mesencephalum of rat embryos (E-14) were implanted. The tissue was grafted into the striatum, pallidum-striatum and pallidum areas of rats with unilateral lesions of the striatonigral bundle. One, two, three and six months after transplantation, the rotatory activity induced by D-amphetamine was evaluated. The rotatory behaviour induced by apomorphine was evaluated at three months. Motor ability of the front legs was evaluated in all experimental groups three months after transplantation using the 'ladder test'. RESULTS: In the experimental groups in which a transplant was made to the globus pallidus there was a significant reduction (p < 0.01) in rotatory activity induced by D-amphetamine and by apomorphine as compared with the non-transplanted groups. CONCLUSIONS: Transplants of foetal dopaminergic cells survive in the globus pallidus of hemiparkinsonian rats and can improve the rotational activity induced by dopaminergic agonists.


Assuntos
Adrenérgicos/efeitos adversos , Corpo Estriado/efeitos dos fármacos , Corpo Estriado/cirurgia , Transplante de Tecido Fetal , Globo Pálido/efeitos dos fármacos , Globo Pálido/cirurgia , Mesencéfalo/embriologia , Mesencéfalo/transplante , Oxidopamina/efeitos adversos , Doença de Parkinson Secundária/induzido quimicamente , Animais , Apomorfina/farmacologia , Agonistas de Dopamina/farmacologia , Masculino , Ratos , Ratos Wistar
2.
Rev Neurol ; 26(152): 554-60, 1998 Apr.
Artigo em Espanhol | MEDLINE | ID: mdl-9796004

RESUMO

OBJECTIVE: The objective of this paper was to review information related to the various factors which may trigger the mechanisms of cell death, induced or programmed, which take place in the nervous system and their relationship with the aetiopathogenesis of the neurodegenerative diseases. DEVELOPMENT: In recent years it has been recognized that cell death may be not only the consequence of accidental damage but also a sign of a suicide programme. This form of death is currently known as apoptosis. It is a process which is morphologically distinct from accidental cell death or necrosis. It does not cause an inflammatory response. This type of death is not only involved in the development and haemostasis of tissues, but also in setting off neuronal degeneration in experimental models of Parkinson's disease, Huntington's chorea, etc. CONCLUSIONS: In the cell death occurring in neurodegenerative diseases there is more than one induction mechanisms. Understanding the factors which trigger cell death, and the chain of events leading to this, gives grounds for the design of new pharmacological strategies for the treatment of these diseases.


Assuntos
Doenças Neurodegenerativas/etiologia , Doenças Neurodegenerativas/patologia , Neurônios/patologia , Cálcio/metabolismo , Morte Celular , Aminoácidos Excitatórios/metabolismo , Humanos , Necrose , Doenças Neurodegenerativas/tratamento farmacológico , Óxido Nítrico/metabolismo , Estresse Oxidativo/fisiologia , Receptores de N-Metil-D-Aspartato/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA